{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:07:13Z","timestamp":1777860433852,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571598"],"award-info":[{"award-number":["81571598"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871299"],"award-info":[{"award-number":["81871299"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program:\"Precise Medical Research\"","award":["2016YFC0906201"],"award-info":[{"award-number":["2016YFC0906201"]}]},{"name":"CAMS Initiative for Innovative Medicine","award":["2016-I2M-1-013"],"award-info":[{"award-number":["2016-I2M-1-013"]}]},{"name":"National Major Science and Technology Research Projects for the Control and Prevention of Major Infectious Diseases in China","award":["2014ZX10003003"],"award-info":[{"award-number":["2014ZX10003003"]}]},{"DOI":"10.13039\/501100004572","name":"National Health and Family Planning Commission of the People\u2019s Republic of China","doi-asserted-by":"crossref","award":["201402001"],"award-info":[{"award-number":["201402001"]}],"id":[{"id":"10.13039\/501100004572","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-3954-y","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T15:04:16Z","timestamp":1555340656000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Diagnostic value of the interferon-\u03b3 release assay for tuberculosis infection in patients with Beh\u00e7et\u2019s disease"],"prefix":"10.1186","volume":"19","author":[{"given":"Xiuhua","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoran","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3165-8185","authenticated-orcid":false,"given":"Wenjie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,15]]},"reference":[{"key":"3954_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/01.lgt.0000225897.29466.e4","volume":"10","author":"M Hamill","year":"2006","unstructured":"Hamill M, Remedios D, Kapembwa M. Orogenital ulceration with overlapping tuberculosis: epiphenomenon or expanding spectrum of Behcet disease? J Low Genit Tract Dis. 2006;10:219\u201322.","journal-title":"J Low Genit Tract Dis"},{"key":"3954_CR2","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1007\/s00296-014-2998-y","volume":"34","author":"K Shinoda","year":"2014","unstructured":"Shinoda K, Hayashi R, Taki H, Hounoki H, Makino T, Nomoto K, et al. Pseudo-Behcet\u2019s disease associated with tuberculosis: a case report and review of the literature. Rheumatol Int. 2014;34:1471\u20134.","journal-title":"Rheumatol Int"},{"key":"3954_CR3","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/0007-0971(88)90073-3","volume":"82","author":"J Efthimiou","year":"1988","unstructured":"Efthimiou J, Hay PE, Spiro SG, Lane DJ. Pulmonary tuberculosis in Beh\u00e7et's syndrome. Br J Dis Chest. 1988;82:300\u20134.","journal-title":"Br J Dis Chest"},{"key":"3954_CR4","first-page":"800","volume":"60","author":"P Ormerod","year":"2005","unstructured":"Ormerod P, Milburn HJ, Gillespie S, Ledingham J, Rampton D. BTS recommendations for assessing risk, and for managing M.tuberculosis infection and disease, in patients due to start anti-TNF treatment. Cytokine. 2005;60:800.","journal-title":"Cytokine."},{"key":"3954_CR5","first-page":"1192","volume":"10","author":"M Farhat","year":"2006","unstructured":"Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis. 2006;10:1192\u2013204.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3954_CR6","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1136\/ard.2004.029041","volume":"64","author":"DPD Le\u00f3n","year":"2005","unstructured":"Le\u00f3n DPD, Acevedov\u00e1squez E, S\u00e1ncheztorres A, Cucho M, Alfaro J, Perich R, et al. Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis. Ann Rheum Dis. 2005;64:1360.","journal-title":"Ann Rheum Dis"},{"key":"3954_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1128\/CMR.00034-13","volume":"27","author":"M Pai","year":"2014","unstructured":"Pai M, Denkinger CM, Kik SV, Rangaka MX, Zwerling A, Oxlade O, et al. Gamma interferon release assays for detection of mycobacterium tuberculosis infection. Clin Microbiol Rev. 2014;27:3\u201320.","journal-title":"Clin Microbiol Rev"},{"key":"3954_CR8","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1177\/0961203310397966","volume":"20","author":"N Takeda","year":"2011","unstructured":"Takeda N, Nojima T, Terao C, Yukawa N, Kawabata D, Ohmura K, et al. Interferon-gamma release assay for diagnosing mycobacterium tuberculosis infections in patients with systemic lupus erythematosus. Lupus. 2011;20:792\u2013800.","journal-title":"Lupus."},{"key":"3954_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF03256394","volume":"14","author":"A Kowada","year":"2010","unstructured":"Kowada A. Cost effectiveness of interferon-gamma release assay for tuberculosis screening of rheumatoid arthritis patients prior to initiation of tumor necrosis factor-alpha antagonist therapy. Mol Diagn Ther. 2010;14:367\u201373.","journal-title":"Mol Diagn Ther"},{"key":"3954_CR10","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s Disease","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s Disease. Criteria for diagnosis of Behcet's disease. Lancet. 1990;335:1078\u201380.","journal-title":"Lancet."},{"key":"3954_CR11","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/jdv.12107","volume":"28","author":"International Team for the Revision of the International Criteria for Beh\u00e7et's Disease","year":"2014","unstructured":"International Team for the Revision of the International Criteria for Beh\u00e7et's Disease. The International Criteria for Beh\u00e7et\u2019s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28:338.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3954_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.7326\/0003-4819-148-5-200803040-00003","volume":"148","author":"DP Dosanjh","year":"2008","unstructured":"Dosanjh DP, Hinks TS, Innes JA, Deeks JJ, Pasvol G, Hackforth S, et al. Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med. 2008;148:325\u201336.","journal-title":"Ann Intern Med"},{"key":"3954_CR13","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1164\/ajrccm.161.4.16141","volume":"161","author":"H Identificatio","year":"2000","unstructured":"Identificatio H. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med. 2000;161:1376\u201395.","journal-title":"Am J Respir Crit Care Med"},{"key":"3954_CR14","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10096-005-1377-8","volume":"24","author":"T Meier","year":"2005","unstructured":"Meier T, Eulenbruch HP, Wrighton-Smith P, Enders G, Regnath T. Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis. 2005;24:529\u201336.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3954_CR15","first-page":"53","volume":"34","author":"F Deck","year":"1964","unstructured":"Deck F, Guld J. The WHO tuberculin test. Bull Int Union Tuberc. 1964;34:53\u201370.","journal-title":"Bull Int Union Tuberc"},{"key":"3954_CR16","doi-asserted-by":"publisher","first-page":"h6747","DOI":"10.1136\/bmj.h6747","volume":"352","author":"LE Hoppe","year":"2016","unstructured":"Hoppe LE, Kettle R, Eisenhut M, Abubakar I. Guideline development group. Tuberculosis--diagnosis, management, prevention,and control: summary of updated NICE guidance. BMJ. 2016;352:h6747.","journal-title":"BMJ."},{"key":"3954_CR17","first-page":"9","volume-title":"Global Tuberculosis Report 2018 Global Tuberculosis Report","author":"Organization WH","year":"2018","unstructured":"Organization WH. Global Tuberculosis Report 2018 Global Tuberculosis Report; 2018. p. 9."},{"key":"3954_CR18","first-page":"1436","volume":"30","author":"L Carmona","year":"2003","unstructured":"Carmona L, Hernandez-Garcia C, Vadillo C, Pato E, Balsa A, Gonzalez-Alvaro I, et al. Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol. 2003;30:1436\u20139.","journal-title":"J Rheumatol"},{"key":"3954_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0891-5520(05)70149-5","volume":"15","author":"E Bouza","year":"2001","unstructured":"Bouza E, Moya JG, Munoz P. Infections in systemic lupus erythematosus and rheumatoid arthritis. Infect Dis Clin N Am. 2001;15:335\u201361.","journal-title":"Infect Dis Clin N Am"},{"key":"3954_CR20","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1002\/art.21382","volume":"52","author":"KL Winthrop","year":"2005","unstructured":"Winthrop KL, Siegel JN, Jereb J, Taylor Z, Iademarco MF. Tuberculosis associated with therapy against tumor necrosis factor alpha. Arthritis Rheum. 2005;52:2968\u201374.","journal-title":"Arthritis Rheum"},{"key":"3954_CR21","first-page":"108","volume":"125","author":"SD Jr","year":"1982","unstructured":"Jr SD. The tuberculin skin test. Am Rev Respir Dis. 1982;125:108\u201318.","journal-title":"Am Rev Respir Dis"},{"key":"3954_CR22","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/thorax.57.9.804","volume":"57","author":"L Wang","year":"2002","unstructured":"Wang L, Turner MO, Elwood RK, Schulzer M, Fitzgerald JM. A meta-analysis of the effect of Bacille Calmette Gu\u00e9rin vaccination on tuberculin skin test measurements. Thorax. 2002;57:804.","journal-title":"Thorax."},{"key":"3954_CR23","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/S0140-6736(06)68579-6","volume":"367","author":"G Ferrara","year":"2006","unstructured":"Ferrara G, Losi M, D'Amico R, Roversi P, Piro R, Meacci M, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with mycobacterium tuberculosis: a prospective study. Lancet. 2006;367:1328\u201334.","journal-title":"Lancet."},{"key":"3954_CR24","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1007\/s10096-012-1674-y","volume":"31","author":"Y Dai","year":"2012","unstructured":"Dai Y, Feng Y, Xu R, Xu W, Lu W, Wang J. Evaluation of interferon-gamma release assays for the diagnosis of tuberculosis: an updated meta-analysis. Eur J Clin Microbiol Infect Dis. 2012;31:3127\u201337.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3954_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/1756-185X.12772","volume":"19","author":"B Jiang","year":"2016","unstructured":"Jiang B, Ding H, Zhou L, Chen X, Chen S, Bao C. Evaluation of interferon-gamma release assay (T-SPOT.TB(\u2122)) for diagnosis of tuberculosis infection in rheumatic disease patients. Int J Rheum Dis. 2016;19:38\u201342.","journal-title":"Int J Rheum Dis"},{"key":"3954_CR26","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1183\/09031936.00019709","volume":"33","author":"C Lange","year":"2009","unstructured":"Lange C, Pai M, Drobniewski F, Migliori GB. Interferon-gamma release assays for the diagnosis of active tuberculosis: sensible or silly? Eur Respir J. 2009;33:1250\u20133.","journal-title":"Eur Respir J"},{"key":"3954_CR27","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.tube.2015.07.002","volume":"95","author":"C Vanessa","year":"2015","unstructured":"Vanessa C, Yu H, Christel Z, Tom C, Nigel C. Interferon gamma release assays for monitoring the response to treatment for tuberculosis: a systematic review. Tuberculosis. 2015;95:639\u201350.","journal-title":"Tuberculosis."},{"key":"3954_CR28","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3201\/eid2403.171633","volume":"24","author":"DT Nguyen","year":"2018","unstructured":"Nguyen DT, Teeter LD, Graves J, Graviss EA. Characteristics associated with negative interferon-\u03b3 release assay results in culture-confirmed tuberculosis patients, Texas, USA, 2013\u20132015. Emerg Infect Dis. 2018;24:534.","journal-title":"Emerg Infect Dis"},{"key":"3954_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1183\/09031936.00114810","volume":"37","author":"M Sester","year":"2011","unstructured":"Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Migliori GB, et al. Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2011;37:100\u201311.","journal-title":"Eur Respir J"},{"key":"3954_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1056\/NEJM200107193450307","volume":"345","author":"PM Small","year":"2001","unstructured":"Small PM, Fujiwara PI. Management of tuberculosis in the United States. N Engl J Med. 2001;345:189\u2013200.","journal-title":"N Engl J Med"},{"key":"3954_CR31","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s10067-012-2049-6","volume":"31","author":"R Scrivo","year":"2012","unstructured":"Scrivo R, Sauzullo I, Mengoni F, Iaiani G, Vestri AR, Priori R, et al. Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents. Clin Rheumatol. 2012;31:1567\u201375.","journal-title":"Clin Rheumatol"},{"key":"3954_CR32","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s10067-012-1938-z","volume":"31","author":"S Minguez","year":"2012","unstructured":"Minguez S, Latorre I, Mateo L, Lacoma A, Diaz J, Olive A, et al. Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment. Clin Rheumatol. 2012;31:785\u201394.","journal-title":"Clin Rheumatol"},{"key":"3954_CR33","first-page":"601737","volume":"2013","author":"A Trajman","year":"2013","unstructured":"Trajman A, Steffen RE, Menzies D. Interferon-gamma release assays versus tuberculin skin testing for the diagnosis of latent tuberculosis infection: an overview of the evidence. Pulm Med. 2013;2013:601737.","journal-title":"Pulm Med"},{"key":"3954_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1183\/09031936.00115110","volume":"37","author":"R Diel","year":"2011","unstructured":"Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, et al. Interferon-gamma release assays for the diagnosis of latent mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J. 2011;37:88\u201399.","journal-title":"Eur Respir J"},{"key":"3954_CR35","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1183\/09031936.00120908","volume":"33","author":"U Mack","year":"2009","unstructured":"Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D, et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J. 2009;33:956\u201373.","journal-title":"Eur Respir J"},{"key":"3954_CR36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/BOR.0b013e3283474d62","volume":"23","author":"R Smith","year":"2011","unstructured":"Smith R, Cattamanchi A, Steingart KR, Denkinger C, Dheda K, Winthrop KL, et al. Interferon-gamma release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders. Curr Opin Rheumatol. 2011;23:377\u201384.","journal-title":"Curr Opin Rheumatol"},{"key":"3954_CR37","doi-asserted-by":"publisher","first-page":"e0141033","DOI":"10.1371\/journal.pone.0141033","volume":"10","author":"JJ Yu","year":"2015","unstructured":"Yu JJ, Woo HI, Jeon K, Koh WJ, Dong KJ, Cha HS, et al. The significance of sensitive interferon gamma release assays for diagnosis of latent tuberculosis infection in patients receiving tumor necrosis factor-\u03b1 antagonist therapy. PLoS One. 2015;10:e0141033.","journal-title":"PLoS One"},{"key":"3954_CR38","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1128\/CVI.05299-11","volume":"18","author":"D Vassilopoulos","year":"2011","unstructured":"Vassilopoulos D, Tsikrika S, Hatzara C, Podia V, Kandili A, Stamoulis N, et al. Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy. Clin Vaccine Immunol. 2011;18:2102\u20138.","journal-title":"Clin Vaccine Immunol"},{"key":"3954_CR39","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10067-014-2817-6","volume":"35","author":"Q Ruan","year":"2016","unstructured":"Ruan Q, Zhang S, Ai J, Shao L, Zhang W. Screening of latent tuberculosis infection by interferon-\u03b3 release assays in rheumatic patients: a systemic review and meta-analysis. Clin Rheumatol. 2016;35:417\u201325.","journal-title":"Clin Rheumatol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3954-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-3954-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3954-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T23:07:35Z","timestamp":1586819255000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-3954-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,15]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3954"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-3954-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,15]]},"assertion":[{"value":"1 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the institutional review board of Peking Union Medical College Hospital (approval number: S-443) and all methods were performed in accordance with the relevant guidelines and regulations. All patients provided written informed consent in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"323"}}